Cargando…
Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function
BACKGROUND: Lung cancer is one of the most lethal cancers worldwide. Cisplatin, a widely used anti‐lung cancer drug, has been limited in clinical application due to its drug resistance. Medicines targeting mitochondrial electron transport chain (ETC) complexes may be effective candidates for cisplat...
Autores principales: | Dong, Jingyao, Zhu, Dongshan, Chen, Mengmeng, Wang, Taiwei, Gao, Yan, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108040/ https://www.ncbi.nlm.nih.gov/pubmed/35429141 http://dx.doi.org/10.1111/1759-7714.14425 |
Ejemplares similares
-
Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism
por: Calderon, Abram, et al.
Publicado: (2020) -
Sodium hydrosulfide mitigates dexamethasone‐induced osteoblast dysfunction by interfering with mitochondrial function
por: Ma, Jun, et al.
Publicado: (2019) -
Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
por: Xu, Qia, et al.
Publicado: (2022) -
Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021) -
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function
por: Yu, Xiaowen, et al.
Publicado: (2018)